Physician profile
Robin A Lauer
NPI 1457469389
$236.71
in general payments reported to CMS, 2019-2025
7 companies · $53.82 in 2025
The $53.82 reported for 2025 was less than what a typical Registered Nurse provider received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.42 · 2023: $42.52 · 2024: $48.95 · 2025: $53.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $91.42 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.61 | 2024-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $27.13 | 2024 | Dupixent |
| Aimmune Therapeutics, INC. | $20.03 | 2025 | Zenpep |
| Merck Sharp & Dohme LLC | $14.76 | 2023 | Dificid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.32 | 2023 | Xifaxan |
| Intercept Pharmaceuticals, INC. | $13.44 | 2023 | Ocaliva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Lauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.